|
WO9213530A1
|
|
Transglutaminase enzyme inhibitors
|
|
IE912252A1
|
|
Improved ointment base and method of use
|
|
AU7687091A
|
|
Antidiarrheal composition and method
|
|
US5114963A
|
|
Method of reducing serum levels of lipoprotein(A)
|
|
US5025018A
|
|
Central nervous system injury treatment with opiate-receptor antagonist
|
|
US5017372A
|
|
Method of producing antibody-fortified dry whey
|
|
WO8809675A1
|
|
Inhibition of arachidonic acid metabolism
|
|
CA1323301C
|
|
Thyrotropin-releasing hormone analogs in cns injury
|
|
CA1322523C
|
|
Central nervous system injury treatment with opiate- receptor antagonists
|
|
CA1322521C
|
|
Thyrotropin-releasing hormone analog composition and use thereof
|
|
CA1322522C
|
|
Traumatic and ischemic brain injury treatment with opiate-receptor antagonists
|
